TL;DR: Cambridge Cancer Genomics is a Y Combinator Summer 2017 startup CCG.ai empowers clinicians to make personalised treatment strategies…, currently inactive with a team of 25.
CCG.ai empowers clinicians to make personalised treatment strategies…
Last verified:
CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have the potential to transform cancer treatment, and enable oncologists to make smarter decisions about which drug to use in which circumstance. We are expanding our team in Cambridge, UK, offering a fantastic opportunity for dedicated individuals who are comfortable in a high-work high-reward environment, and who are enthusiastic for a dynamic and varied role. We are looking for people who fit well into our team and company culture, and who like to overcome challenges and drive…
Built by LemStudio
Yes. Cambridge Cancer Genomics was funded by Y Combinator in the Summer 2017 batch. CCG.ai empowers clinicians to make personalised treatment strategies…
CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop data-driven biomarkers indicative of treatment response. We believe that increasing amounts of clinical and genomic data have…
Cambridge Cancer Genomics was part of Y Combinator's Summer 2017 batch.
Cambridge Cancer Genomics has a team of 25 people according to Y Combinator's directory.
Cambridge Cancer Genomics is currently listed as Inactive with a team of 25 in Y Combinator's directory.
Loading interactive view…